drugset / Trial / NCT02596997
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Summary
Provide patients with serious AdV infection or disease access to treatment with BCV.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brincidofovir | Other / unclassified | 100 mg | — |